Significant Ownership of Innoviva, Inc.
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Innoviva, Inc. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Pavel Raifeld - Pavel Raifeld, Chief Executive Officer
- Manager location
- Burlingame, CA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
CIK context first
Continue from Innoviva, Inc.
Significant Ownership of Innoviva, Inc.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ARMP | Armata Pharmaceuticals, Inc. | Common Stock, $0.01 par value | 83% | $567,986,780 | 55,467,459 | 0% | Innoviva, Inc. | 12 May 2026 |
Schedules 13D/G Reported by Innoviva, Inc.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.